Aripiprazole Tablet
FDA Label NDC 70518-0970

54 label sections · Submitted to the FDA by Remedyrepack Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Remedyrepack Inc. for the product Aripiprazole (NDC 70518-0970). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: increased mortality in elderly patients with dementia-related psychosis and suicidal thoughts and behaviors with antidepressant drugs, 1  indications and usage, 2.1 schizophrenia, 2.4 irritability associated with autistic disorder, 2.5 tourette’s disorder, 2.6 dosage adjustments for cytochrome p450 considerations, 3 dosage forms and strengths, 4  contraindications, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.